TMO Thermo Fisher Scientific Inc | US8835561023
| Metric | Current | 30.06.2026 | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|---|
| Market Cap | 211.177.619.456 | 186.004.554.565,43 | 182.663.098.237,81 | 218.001.535.384,05 | 182.225.918.648,53 |
| Enterprise Value | 249.430.458.368 | 186.004.554.565,43 | 222.570.098.237,81 | 247.534.535.384,05 | 215.923.918.648,53 |
| Trailing P/E | 30,58 | 35,56 | 26,67 | 32,52 | 38,44 |
| Forward P/E | 20,69 | - | - | - | - |
| Price to Sales | 4,56 | 5,42 | 4,04 | 4,89 | 5,63 |
| Price to Book | 4,07 | - | 3,52 | 4,08 | 3,57 |
| EV/Revenue | 5,38 | 5,42 | 4,92 | 5,56 | 6,68 |
| EV/EBITDA | 21,25 | 20,39 | 18,54 | 20,88 | 25,18 |